Drug Shortage Report for TARO-CEFPROZIL
| Report ID | 169484 |
| Drug Identification Number | 02329204 |
| Brand name | TARO-CEFPROZIL |
| Common or Proper name | CEFPROZIL |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFPROZIL |
| Strength(s) | 125MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 75 |
| ATC code | J01DC |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-09 |
| Estimated end date | 2023-08-18 |
| Actual end date | 2023-08-21 |
| Shortage status | Resolved |
| Updated date | 2024-02-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-09-16 | English | Compare |
| v2 | 2022-09-16 | French | Compare |
| v3 | 2022-11-03 | English | Compare |
| v4 | 2022-11-03 | French | Compare |
| v5 | 2022-11-16 | English | Compare |
| v6 | 2022-11-16 | French | Compare |
| v7 | 2022-11-25 | English | Compare |
| v8 | 2022-11-25 | French | Compare |
| v9 | 2022-12-08 | English | Compare |
| v10 | 2022-12-12 | English | Compare |
| v11 | 2022-12-12 | French | Compare |
| v12 | 2023-01-10 | English | Compare |
| v13 | 2023-01-10 | French | Compare |
| v14 | 2023-01-20 | English | Compare |
| v15 | 2023-01-20 | French | Compare |
| v16 | 2023-02-01 | English | Compare |
| v17 | 2023-02-01 | French | Compare |
| v18 | 2023-03-10 | English | Compare |
| v19 | 2023-03-10 | French | Compare |
| v20 | 2023-03-24 | English | Compare |